Background The best treatment for carbapenem-resistant Acinetobacter baumannii (CRAB)
infections is still a matter of debate. Objectives To describe the outcomes of patients treated …

Introduction Klebsiella pneumoniae is a major agent of healthcare-associated infections and
a cause of some community-acquired infections, including severe bacteremic infections …

Purpose Cefiderocol susceptibility testing (AST) represents an open challenge for clinical
microbiology. Herein, we evaluated the performance of the UMIC® Cefiderocol broth …

Purpose To test cefiderocol, a siderophore-cephalosporin antibiotic for topical monotherapy
treatment of experimental extensively drug-resistant (XDR) Pseudomonas aeruginosa …

Nosocomial pneumonia, including hospital-acquired pneumonia and ventilator-associated
pneumonia, is the leading cause of death related to hospital-acquired infections among …

Introduction Cefiderocol is a siderophore cephalosporin showing activity against various
carbapenem-resistant Gram-negative bacteria (CR-GNB). No data currently exist about real …

Antibiotics have remained the cornerstone for the treatment of bacterial infections ever since
their discovery in the twentieth century. The uproar over antibiotic resistance among bacteria …

Background Achromobacter spp. are opportunistic pathogens, mostly infecting
immunocompromised patients and patients with cystic fibrosis (CF) and considered as …

Acinetobacter baumannii has emerged as a pressing challenge in clinical practice, mainly
due to the development of resistance to multiple antibiotics, including colistin, one of the last …

In this Commentary, we discuss the main findings of a systematic review with meta-analysis
of in vitro susceptibility data for cefiderocol against gram-negative bacilli. We then put these …